Table 2 CircRNAs regulate the expression of PD-L1 in different cancers.
Cancer types | CircRNAs | Mechanisms | Roles | PD-L1 expression | Ref. |
---|---|---|---|---|---|
Lung cancer | circRNA-002178↑ | miR-34a↓(in tumor cells) ;miR-28-5p↓(in T cells) | May be a biomarker for LUAD diagnosis | PD-L1 ↑ ; PD-1↑ | [164] |
circ_0000284↑ | miR-377-3p↓ | Induces NSCLC cells migration, invasion, and proliferation | PD-L1↑ | [165] | |
circ-CPA4↑ | let-7 miRNA↓ | Promotes NSCLC cells growth, stemness and resistance to cisplatin | PD-L1↑ | [166] | |
circ‑HSP90A↑ | miR‑424‑5p↓ | Promotes NSCLC cells growth, stemness and inhibits CD8+ T cell function | PD-L1↑ | [167] | |
hsa_circ_0068252↑ | miR-1304-5p↓ | Associated with poor prognosis and cisplatin resistance | PD-L1↑ | [168] | |
circCHST15↑ | miR-155-5p and miR-194-5p↓ | Associated with clinical staging of tumors and immune evasion | PD-L1↑ | [169] | |
circ_001678↑ | miR-326↓→ZEB1↑ | Induces immune escape | Activates PD-1/PD-L1 signal path | [170] | |
circ_0014235↑ | miR-146b-5p↓→YAP↑ | Induces Gefitinib resistance and malignant behaviors | PD-L1↑ | [171] | |
CRC | hsa_circ_0020397↑ | miR-138↓→TERT↑ | Promotes CRC cell viability and invasion, inhibit apoptosis | PD-L1↑ | [172] |
CDR1‑AS↑ | CMTM4 and CMTM6↑ | Associated with poor prognosis | PD-L1↑ | [173] | |
hsa_circ_0136666↑ | miR-497↓ | Accelerates CRC cell proliferation, inhibits apoptosis, and promotes immune escape | PD-L1↑ | [174] | |
HCC | circCORO1C↑ | NF- κB↑→c-Myc and COX-2↑ | Promotes the proliferation, invasion, and metastasis of HCC cells | PD-L1↑ | [175] |
circPRDM4 | circPRDM4 binds to HIF-1α and recruits it to the CD274 promoter, promoting HIF-1α-mediated transcriptional activation of PD-L1 | Promotes tumor growth and immune escape, and its high expression is associated with better anti-PD-1 mAb treatment | PD-L1↑ | [176] | |
HNSCC | circ_0000052↑ | miR-382-3p↓ | Promotes migration, invasion, and proliferation of HNSCC cells | PD-L1↑ | [177] |
nasopharyngeal carcinoma | circBART2.2↑ | Bind to RIG-I protein→ activate IRF3 and NF-kB | Cause immune escape of nasopharyngeal carcinoma | PD-L1↑ | [178] |
breast cancer | hsa_circ_0001598↑ | miR‑1184↓ | Induces trastuzumab‑resistance | PD-L1↑ | [179] |
hsa_circ_0067842↑ | Interacts with HuR, affecting its nuclear transposition→ CMTM6↑ | CMTM6 not only enhances the migration and invasion ability of BC cells but also affects the ubiquitination of PD-L1 and inhibits its degradation. | PD-L1↑ | [180] | |
Diffuse large B-cell lymphoma | circPCBP2↑ | miR-33a/b↓ | Induce tumor cell stemness and CHOP resistance | PD-L1↑ | [181] |